Back

C Reactive Protein, Albumin, Lymphocyte(CALLY) index predicts 12 month need for durable LVAD in patients with HFrEF

10 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Identification and diagnosis of heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Fatmanur Oguz

Ankara Etlik City Hospital, Ankara (Turkiye)

5 More presentations in this session

Presentation thumbnail
Obesity and post-discharge outcomes in hospitalized patients with heart failure: a real-world cohort study
Doctor R. Lozano Corral (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Real-world identification of patients with HFpEF in a tertiary hospital in the Netherlands: the IDENTIFY-HFpEF study
Assistant Professor A. Uijl (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Short- and long-Term mortality in patients hospitalized for dyspnea with acute heart failure, respiratory infection, or both: insights from the PARADISE cohort
Professor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes and latent risk in HFimpEF: insights from real-world data
Doctor R. Santos (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Timelines of the first heart failure consultation and outcomes in HFrEF: establishing a temporal threshold for follow-up
Doctor R. Santos (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Identification and diagnosis of heart failure

The Event

Event poster

Heart Failure 2026

10 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Session
Acute, advanced and worsening heart failure: prognostic aspects
thumbnail
Congress Session
Young Investigator Award (YIA) Clinical Cardiology
thumbnail
Congress Session
Advanced therapies in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources